For philanthropists interested in pursuing a social change agenda in ways that could also generate a financial return, impact investing is an attractive option. Most high-capacity impact investors consider this activity to be a supplement rather than a replacement to their charitable contributions.
What is impact investing?
Impact investing is the act of financing an organization or fund that aims to provide a social or environmental impact in addition to a financial return, which can range from below-market to market-rate. Impact investing's legal and regulatory framework remains largely untested, so individuals who participate in this practice are often more risk-tolerant than the traditional philanthropist.
How should I approach impact investing?
Because different financial institutions support this option to varying extents, consulting with your wealth manager to determine how you can best incorporate this method into your larger investment portfolio is highly recommended. You may even consider working with a niche advisor who can provide specialized assistance as a supplement to the existing financial support you receive from your wealth manager.
How much risk is involved with impact investing?
The field is still in the process of developing a regulatory framework. Engaging in this practice now would include you among the early adopters. If this aligns with your appetite for risk, you can start impact investment immediately.
Additional Resources:
New to impact investing? Review the Case Foundation’s primer.
This publication from Investing for Good provides guidelines on the various steps of impact investment, from identifying and vetting an opportunity to deal-making and evaluating impact.
The Toniic Impact Portfolio Tool is an Excel-based resource for you to classify investment types and their potential for impact so you can build your impact investing portfolio.
The key lessons that policymakers must learn from the pandemic This article is the ninth in a weekly joint series on “The COVID-19 Pandemic and the Future of Aging” from the Milken Institute Center for the Future of Aging and Next Avenue...
What this thought leader thinks could improve the US response to the pandemic In this interview series from the Milken Institute Center for the Future of Aging and PBS' Next Avenue, experts from the Center's Advisory Board share their...
Future of Aging Advisory Board Academic and Policy Council Member
A world-renowned geriatrician and epidemiologist, Linda Fried has defined frailty and its causes, conducted research on the prevention of disability and cardiovascular disease, and proposes that investments in health for longer lives could build a Third Demographic Dividend.
Why this expert thinks a person-centered approach will be critical In this interview series from the Milken Institute Center for the Future of Aging and PBS' Next Avenue, experts from the Center's Advisory Board share their perspectives on...
Future of Aging Advisory Board Leadership Council Member
Robert Kramer is Founder and Strategic Advisor at the National Investment Center for Seniors Housing & Care (NIC), a non-profit education and resource center that serves debt and equity investors interested in the seniors housing and care industry.
Insights from the former secretary of Housing and Urban Development This article is the eleventh in a weekly joint series on “The COVID-19 Pandemic and the Future of Aging” from the Milken Institute Center for the Future of Aging and Next...
Overview As Big Tech companies face continued scrutiny over their handling of personal health information, the limitations of US health privacy regulation in a digital age are becoming more evident. Policymakers, both in the US and around...
Nobel Laureate Elizabeth Blackburn on how the pandemic may, and must, change things. This article is the twentieth in a weekly joint series on “The COVID-19 Pandemic and the Future of Aging” from the Milken Institute Center for the Future...
Future of Aging Advisory Board Academic and Policy Council Member
Throughout her long career in science, Dr. Blackburn has been a leader in the area of telomere and telomerase research, having discovered the molecular nature of telomeres – the ends of eukaryotic chromosomes that serve as protective caps essential for preserving the genetic information – and co-discovered the ribonucleoprotein enzyme, telomerase. She is also known for her championing of diversity and inclusion in the sciences.
The pandemic’s impacts on disease prevention, science, and innovation In this interview series from the Milken Institute Center for the Future of Aging and PBS' Next Avenue, experts from the Center's Advisory Board share their perspectives...
Kevin Crain discusses solutions to the four retirement challenges employees face This article is the sixteenth in a weekly joint series on “The COVID-19 Pandemic and the Future of Aging” from the Milken Institute Center for the Future of...
In This Newsletter Tech in Rwanda AI at the Asia Summit Election Event Contracts The Emerging Tech Ecosystem in Rwanda In a conversation with Milken Institute CEO Rich Ditizio at the 2024 Milken Institute Asia Summit, President Paul Kagame...
Maxwell DeGregorio is an associate at MI Finance at the Milken Institute. DeGregorio works on the Institute’s FinTech Program, which focuses on access to capital, financial inclusion, compliance, and transparency. He writes the “FinTech in Focus” newsletter and co-programs the Institute’s FinTech content.